Research
AI matches the accuracy of expert radiologists to detect prostate cancer in a major multi-centre clinical study
Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce the results of a 5-year collaboration. The PAIR-1 study shows that the Pi AI software, now in use in NHS and European hospitals, is the first commercial product of its kind with performance equivalent to that of expert...
No one talks about the messy middle - we do
The messy middle is where real progress happens, tough decisions are made, and leaders are forged. At this year’s Business of Software Conference Europe, we’re discussing frameworks, strategies, and lessons that help you push through uncertainty and come out stronger. ...
Business of Software Europe 2025
Spend two days with smart, ambitious SaaS and software entrepreneurs who are serious about building great products and companies. Forget the noise of poor, generic advice from forums, books, and events – at BoS, it’s about learning what actually works.Cambridge Network members get 10% d...
Babraham Institute Enterprise welcomes four new Board Members to its Board
The Institute is delighted to welcome four new Non-Executive Directors to the Board of Babraham Institute Enterprise (BIE) Ltd. The new Board Directors bring extensive experience in translating fundamental research discoveries for commercial use as well as expertise in how to feed-forwa...
Purpose-built progress: key trends shaping cell and gene therapy in 2025
In recent years the cell and gene therapy industry has been fast-growing, with over 1,200 therapies now in clinical trials globally, across an ever-expanding array of indications. Despite this rapid growth, the industry is struggling to meet the demand for the manufacturing of therapies...
Cambridge AI Club for Biomedicine - March - Foundation Models
The AI Club brings together the Biomedical AI and Machine Learning community in Cambridge, to discuss common themes and explore different topics and methodologies. ...
Research challenges our understanding of cancer predisposition
Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumours grow in those with genetic condition neurofibromatosis type 1 (NF-1). Understanding more about the factors involved could, in the future, facilitate early cancer d...
Cambridge 2030: Power of Purpose & Partnership
Mark your calendar for Cambridge 2030's mission driven conference: Power of Purpose & Partnership ...
Why the discovery phase is crucial for your WordPress website project
When planning the design and development of a new WordPress website, it’s easy to focus on budget. After all, you want to ensure your investment is affordable while delivering strong returns. From that starting point, it might seem logical to ask what can be achieved within your spendin...
Sortera Bio spins out of the MRC Laboratory of Molecular Biology to pioneer new frontiers in biologics discovery
New UK-based biotechnology company launched to realise therapeutic potential of deep screening technology developed at the Medical Research Council Laboratory of Molecular Biology (MRC LMB). ...